ITW
39
2
AXP
69
-2
VFC
70
-2
EBAY
52
4
PYPL
50
-24
LB
33
11
SO
48
-29
PSA
46
-18
FLS
46
-4
XYL
25
-35
MLM
61
-5
IVZ
68
2
GIS
64
3
ADP
66
4
BIIB
48
2
EA
44
-3
CSCO
56
-2
EQR
44
5
NOC
51
-3
MCK
64
-2
ITW
39
2
AXP
69
-2
VFC
70
-2
EBAY
52
4
PYPL
50
-24
LB
33
11
SO
48
-29
PSA
46
-18
FLS
46
-4
XYL
25
-35
MLM
61
-5
IVZ
68
2
GIS
64
3
ADP
66
4
BIIB
48
2
EA
44
-3
CSCO
56
-2
EQR
44
5
NOC
51
-3
MCK
64
-2
Financhill
Back

Rayliant Quantitative Developed Market Equity ETF Vs. Aligos Therapeutics, Inc. Industry Stock Comparison

Sell
43

RAYD
Rayliant Quantitative Developed Market Equity ETF

Last Price:
$37.55
Seasonality Move:
3.83%
Buy
63

ALGS
Aligos Therapeutics, Inc.

Last Price:
$10.43
Seasonality Move:
-7.27%
Sell
43
Rayliant Quantitative Developed Market Equity ETF (RAYD) is a Sell

Is Rayliant Quantitative Developed Market Equity ETF a Buy, Sell or Hold?

  • The current Rayliant Quantitative Developed Market Equity ETF [RAYD] share price is $37.75. The Score for RAYD is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RAYD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Aligos Therapeutics, Inc. (ALGS) is a Buy

Is Aligos Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Aligos Therapeutics, Inc. [ALGS] share price is $10.63. The Score for ALGS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RAYD Stock Price Chart

What is Rayliant Quantitative Developed Market Equity ETF's stock price today?

  • The Rayliant Quantitative Developed Market Equity ETF share price today is $37.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics, Inc.'s stock price today?

  • The Aligos Therapeutics, Inc. share price today is $10.63
    The current trend is moderately bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

RAYD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.01 Buy
Relative Strength Index (14 RSI): 50.6 Buy
Chaikin Money Flow: -17637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.92 - 38.18) Buy
Bollinger Bands (100): (36.73 - 37.93) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 54.05 Buy
Chaikin Money Flow: -61767 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.78 - 11.34) Buy
Bollinger Bands (100): (7.93 - 10.79) Buy

RAYD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.02 Sell
20-day SMA: 37.55 Buy
50-day SMA: 37.58 Buy
200-day SMA: 35.58 Buy
8-day EMA: 8.39 Buy
20-day EMA: 3.59 Buy
50-day EMA: 1.48 Buy
200-day EMA: 0.38 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.51 Sell
20-day SMA: 10.24 Buy
50-day SMA: 9.25 Buy
200-day SMA: 8.39 Buy
8-day EMA: 11.24 Sell
20-day EMA: 10.39 Buy
50-day EMA: 9.63 Buy
200-day EMA: 10.54 Buy

Rayliant Quantitative Developed Market Equity ETF Earnings Growth & RAYD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics, Inc. Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.

Rayliant Quantitative Developed Market Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):